Background Pathogenic variants in BRCA1 and BRCA2 (BRCA1/2) lead to increased risk of
breast, ovarian, and other cancers, but most variant-positive individuals in the general …

Purpose Adoption of genome sequencing (GS) as a first-line test requires evaluation of its
diagnostic yield. We evaluated the GS and targeted gene panel (TGP) testing in diverse …

Background The COVID-19 pandemic forced healthcare institutions and many clinical
research programs to adopt telehealth modalities in order to mitigate viral spread. With the …

The increased use of next‐generation sequencing has expanded our understanding of the
involvement and prevalence of mosaicism in genetic disorders. We describe a total of eleven …

Background Increasingly, genomics is informing clinical practice, but challenges remain for
medical professionals lacking genetics expertise, and in access to and clinical utility of …

Purpose As polygenic risk scores (PRS) emerge as promising tools to inform clinical care,
there is a pressing need for patient-centered evidence to guide their implementation, …

The descriptor ‘usual care’ refers to standard or routine care. Yet, no formal definition exists.
The need to define what constitutes usual care arises in clinical research. Often one arm in a …

Objective Genomics is increasingly used for diagnostic testing in children. This study describes
the expectations of parents whose child received genomic testing and whether or not …

Copy number variations (CNVs) play a significant role in human disease. While chromosomal
microarray has traditionally been the first‐tier test for CNV detection, use of genome …

Digital solutions are needed to support rapid increases in the application of genetic/genomic
tests (GTs) in diverse clinical settings and patient populations. We developed GUÍA, a …